跳至主要内容
临床试验/NCT00491712
NCT00491712Unknown不适用

Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection

Federal University of São Paulo2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2005年9月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
49
试验地点
2
主要终点
intra ocular pressure after the surgery in both groups

研究概览

简要总结

The management of neovascular glaucoma (NVG) is a challenge for the ophthalmologist and surgery is frequently needed to control IOP. The success rates of a drainage device is usually lower in NVG than in other forms of glaucoma. Triamcinolone intra-vitreous injections acetate has been used to treat macular edema secondary to diabetic retinopathy and central retinal vein occlusion and also to control inflammation in ophthalmologic surgeries.

In the present study we will compare the outcome and complications of Silicone Ahmed Valve in GNV eyes with and without intra-vitreous triamcinolone injection.

详细描述

The management of neovascular glaucoma (NVG) is a challenge for the ophthalmologist and surgery is frequently needed to control intraocular pressure (IOP). The success rates of a drainage device is usually lower in NVG than in other forms of glaucoma. Triamcinolone intra-vitreous injections acetate has been used to treat macular edema secondary to diabetic retinopathy and central retinal vein occlusion and also to control inflammation in ophthalmologic surgeries.

In the present study we will compare the outcome and complications of Silicone Ahmed Valve in GNV eyes with and without intra-vitreous triamcinolone injection.

49 Patients with clinically uncontrolled neovascular glaucoma were selected from the glaucoma sector of Federal university of Sao Paulo. After retinal panfotocoagulation (RPF), patients who still are uncontrolled are enrolled to the study. Patients were randomized to one of two groups:

  1. Silicone Ahmed Implant
  2. Silicone Ahmed Implant with intra-vitreous Triamcinolone injection

Inclusion Criteria:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with NVG and uncontrolled IOP despite the use of maximum tolerated glaucoma medication
  • Patients over 18 years old.
  • Patients who can understand and sign the inform consent form.

排除标准

  • Active Sclerites
  • Uveitic Neovascular glaucoma
  • Previous psiquiatric condition
  • Patients who can understand and sign the inform consent form
  • Visual acuity worse than hand motion
  • Previous retina surgery with buckle implant

结局指标

主要结局

intra ocular pressure after the surgery in both groups

时间窗: monthly

次要结局

  • complication rates after surgery(monthly)

研究者

发起方
Federal University of São Paulo
申办方类型
Other

研究点 (2)

Loading locations...

相似试验